Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 15;22(1):566.
doi: 10.1186/s12884-022-04896-5.

'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda

Affiliations

'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda

Yussif Alhassan et al. BMC Pregnancy Childbirth. .

Abstract

Background: Many women in sub-Saharan Africa initiate antenatal care (ANC) late in pregnancy, undermining optimal prevention of mother-to-child-transmission (PMTCT) of HIV. Questions remain about whether and how late initiation of ANC in pregnancy is related to adherence to antiretroviral therapy (ART) in the era of national dolutegravir roll-out.

Methods: This study employed a qualitative design involving individual interviews and focus group discussions conducted between August 2018 and March 2019. We interviewed 37 pregnant and lactating women living with HIV selected purposively for early or late presentation to ANC from poor urban communities in South Africa and Uganda. Additionally, we carried out seven focused group discussions involving 67 participants in both countries. Data were analysed thematically in NVivo12.

Results: Women described common underlying factors influencing both late ANC initiation and poor ART adherence in South Africa and Uganda. These included poverty and time constraints; inadequate health knowledge; perceived low health risk; stigma of HIV in pregnancy; lack of disclosure; and negative provider attitudes. Most late ANC presenters reported relationship problems, lack of autonomy and the limited ability to dialogue with their partners to influence household decisions on health and resource allocation. Perception of poor privacy and confidentiality in maternity clinics was rife among women in both study settings and compounded risks associated with early disclosure of pregnancy and HIV. Women who initiated ANC late and were then diagnosed with HIV appeared to be more susceptible to poor ART adherence. They were often reprimanded by health workers for presenting late which hampered their participation in treatment counselling and festered provider mistrust and subsequent disengagement in care. Positive HIV diagnosis in late pregnancy complicated women's ability to disclose their status to significant others which deprived them of essential social support for treatment adherence. Further, it appeared to adversely affect women's mental health and treatment knowledge and self-efficacy.

Conclusions: We found clear links between late initiation of ANC and the potential for poor adherence to ART based on common structural barriers shaping both health seeking behaviours, and the adverse impact of late HIV diagnosis on women's mental health and treatment knowledge and efficacy. Women who present late are a potential target group for better access to antiretrovirals that are easy to take and decrease viral load rapidly, and counselling support with adherence and partner disclosure. A combination of strengthened health literacy, economic empowerment, improved privacy and patient-provider relationships as well as community interventions that tackle inimical cultural practices on pregnancy and unfair gender norms may be required.

Keywords: Adherence to antiretroviral therapy; Antenatal care; Antenatal care initiation; Antiretroviral therapy; Booking; Dolutegravir; South Africa; Uganda; Women living with HIV.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Relationship between late initiation of antenatal care and poor adherence to antiretroviral therapy among women living with HIV in Uganda and South Africa. Legend: Diagram depicts the overlap between late ANC initiation and poor ART adherence based on the socioecological model [29]. The innermost (blue) circle demonstrates the direct pathways through which late ANC booking and related HIV diagnosis late in pregnancy lead to poor ART adherence. The outer (grey) circles show common underlying factors at the individual, interpersonal, facility and community levels that shape health seeking behaviour (both ANC initiation and ART adherence) of HIV positive women during pregnancy

Similar articles

Cited by

References

    1. Phillips T, Thebus E, Bekker LG, Mcintyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: A cohort study. J Int AIDS Soc. 2014;17:1–10. - PMC - PubMed
    1. Myer L, Zulliger R, Bekker LG, Abrams E. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study. BMC Pregnancy Childbirth. 2012;12(1):1. - PMC - PubMed
    1. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;49(3):276–81. - PMC - PubMed
    1. Alhassan Y, Twimukye A, Malaba T, Orrell C, Myer L, Waitt C, et al. Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: A qualitative study with stakeholders in South Africa and Uganda. BMC Health Serv Res. 2020;20(1):1–12. - PMC - PubMed
    1. Alhassan Y, Twimukye A, Malaba T, Orrell C, Myer L, Waitt C, et al. Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda. BMC Public Health. 2020;20(1):1–12. - PMC - PubMed

Substances